Title : 48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.

Pub. Date : 2014

PMID : 25188312






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Adjusting for the effect of NRTI backbone, treatment with DTG resulted in significantly higher odds of virologic suppression (HIV RNA<50 copies/mL) and increase in CD4+ cells/microL versus ATV/r, DRV/r, EFV, LPV/r, and RPV. dolutegravir CD4 molecule Homo sapiens